Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-07-12
1993-11-23
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 530331, 548253, 548409, 548411, 548469, A61K 3702, C07K 506, C07K 508
Patent
active
052644197
ABSTRACT:
Novel peptoids of .alpha.-substituted Trp derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further the compounds are antianxiety agents and antiulcer agents. They are agents useful for preventing the response to withdrawal from chronic treatment or use of nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. The compounds are also useful in the treatment and/or prevention of panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the peptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare diagnostic compositions.
REFERENCES:
patent: 4757151 (1988-07-01), Horwell
patent: 5010076 (1991-04-01), Waldeck et al.
Horwell David C.
Pritchard Martyn C.
Roberts Edward
Anderson Elizabeth M.
Lee Lester L.
Warner-Lambert & Company
LandOfFree
N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1848949